… In fact, numerous biomarkers have been studied in HCC, but alpha‐fetoprotein (AFP) remains
the most widely used and accepted serum marker since its discovery over 60 years ago. …

… Most recommendations of clinical guidelines were the same as the conclusions of this
meta-analysis [17], but some studies suggested that DCP could diagnosis early-stage …

… , we found that this study was the main source of the heteregeneity in this meta-analysis,
and after the exclusion of this study, the HR estimate decreased to 0.40 (95%CI, 0.33-0.49), as …

… Alpha-fetoprotein was first identified in human fetal sera by Bergstrand and Czar in 1956,
and its use as a tumor marker for HCC was first proposed in the 1960s. Alpha-fetoprotein is a …

… Raised alphafetoprotein in maternal serum with anencephalic pregnancy. Lancet. 1973; 2: …
Immature teratoma producing alphafetoprotein without components of yolk sac tumor in the …

Alpha-fetoprotein (AFP) is an oncofetal glycoprotein that has been used as a tumor marker
for hepatocellular carcinoma (HCC) in combination with ultrasound and other imaging …

Alpha-fetoprotein (AFP) is a glycoprotein that plays an important role in immune regulation
with critical involvement in early human development and maintaining the immune balance …

… Surveillance with alpha-fetoprotein (AFP) in combination with abdominal ultrasonography
every 6 … for HCC and their use in conjunction with serum alpha-fetoprotein (AFP) is reviewed. …

Background: Patients with hepatitis C virus (HCV) are at increased risk for hepatocellular
carcinoma. Although serum α-fetoprotein (AFP) is often used to detect hepatocellular …

… Summary receiver operating characteristic (SROC) curve for the detection of HCC by
alpha-fetoprotein. The figures near circles indicate the cutoff values used in the different studies. …